Erythropoiesis-stimulating agents and antibody-mediated pure red-cell aplasia:: where are we now and where do we go from here?

被引：42

作者：

Locatelli, F ^{[1
]}

Aljama, P

Barany, P

Canaud, B

Carrera, F

Eckardt, KU

Macdougall, IC

Macleod, A

Hörl, WH

Wiecek, A

Cameron, S

机构：

[1] Osped Alessandro Manzoni, Dept Nephrol & Dialysis, Div Nefrol & Dialisi, I-23900 Lecce, Italy

[2] Hosp Univ Reina Sofia, Serv Nefrol, Cordoba, Spain

[3] Huddinge Univ Hosp, Karolinska Inst, Dept Clin Sci, Div Renal Med, Stockholm, Sweden

[4] Lapeyronie Univ Hosp, Dept Nephrol, Montpellier, France

[5] Hosp SAMS, Dept Nephrol & Dialysis, Lisbon, Portugal

[6] Humboldt Univ, Bereich Med Charite, Dept Nephrol & Med Intens Care, D-1040 Berlin, Germany

[7] Kings Coll Hosp London, Dept Renal Med, London, England

[8] Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen, Scotland

[9] Univ Vienna, Dept Med 3, Div Nephrol & Dialysis, Vienna, Austria

[10] Silesian Univ, Sch Med, Dept Nephrol Endocrinol & Metab Dis, Katowice, Poland

[11] Guys St Thomas & Kings Med Sch, Dept Nephrol & Transplantat, London, England

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2004年 / 19卷 / 02期

关键词：

anaemia; antibodies; guidelines; pure red-cell aplasia; rHuEpo;

D O I：

10.1093/ndt/gfg489

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：288 / 293

页数：6

共 20 条

[1]

BERGREM H, 1993, ERYTHROPOIETIN, P265

[2] Drug-induced autoimmune red-cell aplasia. [J].

Bunn, HF .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (07) :522-523

[3] Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. [J].

Casadevall, N ;

Nataf, J ;

Viron, B ;

Kolta, A ;

Kiladjian, J ;

Martin-Dupont, P ;

Michaud, P ;

Papo, T ;

Ugo, V ;

Teyssandier, I ;

Varet, B ;

Mayeux, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (07) :469-475

[4] Antibodies against rHuEPO: native and recombinant [J].

Casadevall, N .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 :42-47

[5] Brief report: Autoantibodies against erythropoietin in a patient with pure red-cell aplasia [J].

Casadevall, N ;

Dupuy, E ;

MolhoSabatier, P ;

Tobelem, G ;

Varet, B ;

Mayeux, P .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (10) :630-633

[6]

CLELAND JL, 1993, CRIT REV THER DRUG, V10, P307

[7] Pure red-cell aplasia due to anti-erythropoietin antibodies [J].

Eckardt, KU ;

Casadevall, N .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (05) :865-869

[8] Development and characterization of novel erythropoiesis stimulating protein (NESP) [J].

Egrie, JC ;

Browne, JK .

BRITISH JOURNAL OF CANCER, 2001, 84 (Suppl 1) :3-10

[9]

Gershon SK, 2002, NEW ENGL J MED, V346, P1584

[10]

Kontsek P, 1999, ACTA VIROL, V43, P63

← 1 2 →